BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 8565794)

  • 21. What treatment options exist for alcohol abuse?
    Dongier M
    J Psychiatry Neurosci; 2003 Jan; 28(1):80. PubMed ID: 12587852
    [No Abstract]   [Full Text] [Related]  

  • 22. [Current aspects of pharmacotherapy of alcoholism].
    Schmidt LG; Dufeu P; Kuhn S; Rommelspacher H
    Nervenarzt; 1995 May; 66(5):323-30. PubMed ID: 7609812
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Current status of alcoholism treatment outcome research.
    Fuller R
    NIDA Res Monogr; 1989; 95():85-91. PubMed ID: 2701325
    [No Abstract]   [Full Text] [Related]  

  • 24. Conference summary: Consensus Conference on Alcohol Dependence and the Role of Pharmacotherapy in its Treatment.
    Chick J; Erickson CK
    Alcohol Clin Exp Res; 1996 Apr; 20(2):391-402. PubMed ID: 8730235
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Naltrexone in the treatment of pathological gambling and alcohol dependence.
    Crockford DN; el-Guebaly N
    Can J Psychiatry; 1998 Feb; 43(1):86. PubMed ID: 9494755
    [No Abstract]   [Full Text] [Related]  

  • 26. Consensus conference on the neuropharmacology of alcohol dependence and the role of pharmacotherapy in its treatment. Amsterdam, The Netherlands, September 16-17, 1994.
    Alcohol Alcohol; 1996 Mar; 31 Suppl 1():1-87. PubMed ID: 8924128
    [No Abstract]   [Full Text] [Related]  

  • 27. Pharmacotherapies for alcohol problems: a review of research with focus on developments since 1991.
    Litten RZ; Allen J; Fertig J
    Alcohol Clin Exp Res; 1996 Aug; 20(5):859-76. PubMed ID: 8865961
    [TBL] [Abstract][Full Text] [Related]  

  • 28. How many cravings? Pharmacological aspects of craving treatment in alcohol addiction: a review.
    Addolorato G; Abenavoli L; Leggio L; Gasbarrini G
    Neuropsychobiology; 2005; 51(2):59-66. PubMed ID: 15741745
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Pharmacotherapy of alcohol use disorders and concurrent psychiatric disorders: a review.
    Lev-Ran S; Balchand K; Lefebvre L; Araki KF; Le Foll B
    Can J Psychiatry; 2012 Jun; 57(6):342-9. PubMed ID: 22682571
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Drugs for relapse prevention of alcoholism: ten years of progress.
    Spanagel R; Kiefer F
    Trends Pharmacol Sci; 2008 Mar; 29(3):109-15. PubMed ID: 18262663
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Neurobehavioural basis for the pharmacotherapy of alcoholism: current and future directions.
    Anton RF
    Alcohol Alcohol; 1996 Mar; 31 Suppl 1():43-53. PubMed ID: 8737000
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Outpatient alcohol detoxification].
    Scherle T; Croissant B; Heinz A; Mann K
    Nervenarzt; 2003 Mar; 74(3):219-25. PubMed ID: 12627236
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A perspective on the effectiveness of interventions for alcohol and other substance use disorders.
    Rush B
    Can J Psychiatry; 2012 Jun; 57(6):339-41. PubMed ID: 22682570
    [No Abstract]   [Full Text] [Related]  

  • 34. Opioid antagonists in the treatment of alcohol dependence: clinical efficacy and prevention of relapse.
    O'Malley SS
    Alcohol Alcohol; 1996 Mar; 31 Suppl 1():77-81. PubMed ID: 8737005
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Pharmacotherapy for Alcohol Use Disorder.
    Holt SR; Tobin DG
    Med Clin North Am; 2018 Jul; 102(4):653-666. PubMed ID: 29933821
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Behavioral health issue brief: pharmacotherapy treatment of alcoholism and drug addiction: overview and bibliography: year end report-2002.
    Colker AC
    Issue Brief Health Policy Track Serv; 2002 Dec; ():1-6. PubMed ID: 12875273
    [No Abstract]   [Full Text] [Related]  

  • 37. Naltrexone: new preparation. Transient preventive efficacy on alcoholic relapse.
    Prescrire Int; 1999 Feb; 8(39):9-11. PubMed ID: 10557566
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Alcoholism: old and new approaches to diagnosis and therapy].
    Meyer T
    Praxis (Bern 1994); 1999 Feb; 88(8):328-32. PubMed ID: 10097642
    [TBL] [Abstract][Full Text] [Related]  

  • 39. New developments in the pharmacotherapy of cocaine abuse.
    Preti A
    Addict Biol; 2007 Jun; 12(2):133-51. PubMed ID: 17508985
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Characteristics of Ongoing Clinical Trials for Alcohol Use Disorder Registered on ClinicalTrials.gov.
    Wallach JD; Krystal JH; Ross JS; O'Malley SS
    JAMA Psychiatry; 2020 Oct; 77(10):1081-1084. PubMed ID: 32459295
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.